As of 2025-11-03, the Relative Valuation of Xphyto Therapeutics Corp (XPHY.CN) is (1.10) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.50 CAD, the upside of Xphyto Therapeutics Corp based on Relative Valuation is -322.8%.
The range of the Relative Valuation is (0.91) - (1.28) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 7.0x - 10.4x | 8.7x |
| Forward P/E multiples | 7.4x - 11.1x | 9.2x |
| Fair Price | (0.91) - (1.28) | (1.10) |
| Upside | -283.7% - -359.2% | -322.8% |
| Date | P/E |